2,3-Dichloro-6-(trifluoromethyl)benzaldehyde, 97.0%, 1g

(1-acetylpiperidin-4-yl)(5-fluoro-2-hydroxyphenyl)methanone, 95.0%, 1g

2-Benzoimidazol-1-yl-N-hydroxy-acetamidine, 95.0%, 2.5g

ethyl 7-oxo-7-[3-(pyrrolidinomethyl)phenyl]heptanoate, 97.0%, 1g

2-Methyl-1H-indole-3-carboxamide, 98%, 1g

5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoic acid, 97%, 100mg

Methyl 5-cyclopropylnicotinate, 95+%, 10g

2',6'-Dihydroxyacetophenone>97.0%(T)25g

6-(dimethylamino)nicotinic acid hydrochloride, 95.0%, 1g

ETHYL 3-(2,6-DICHLOROPHENYL)-5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLATE, 95.0%, 2g

Sodium polytungstate hydrate, min. 99.9%, 50 g, plastic packaging.

6-Methoxypyridazin-4-amine, 98%, 100mg

2-(2-Bromoethyl)-1,3-dioxolane>90.0%(GC)100g